國立高雄大學圖資館 |

登入

回首頁

Chemical biology and drug discovery

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Chemical biology and drug discoveryby Marco F. Schmidt.
作者:	Schmidt, Marco F.
出版者:	Berlin, Heidelberg :Springer Berlin Heidelberg :2022.
面頁冊數:	ix, 223 p. :ill. (chiefly col.), digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Chemical biology.
電子資源:	https://doi.org/10.1007/978-3-662-64412-6
ISBN:	9783662644126$q(electronic bk.)

Chemical biology and drug discovery
Schmidt, Marco F.

Chemical biology and drug discovery[electronic resource] /by Marco F. Schmidt. - Berlin, Heidelberg :Springer Berlin Heidelberg :2022. - ix, 223 p. :ill. (chiefly col.), digital ;24 cm.

Foreword -- Introduction -- Part I: Chemical Biology and Drug Development -- Chemical Biology - a Holistic Science -- Drug Development -- From Genomics to Chemical Biology -- Part II: DNA -- DNA - blueprint of proteins -- Genomic Variation -- Gene Therapy and Genome Editing -- Part III: RNA -- RNA - information and function carrier -- RNA Interference in Drug Development -- Part IV: Proteins -- Peptides & proteins -- Proteins as drug targets -- Chemical genomics - From target protein to drug -- From target protein to macromolecular drug - Biologics -- Chemical proteomics: From drug to target protein -- Chemical genetics: validation of drug target by elucidation of signaling pathway -- Chemical biology - Addressing new drug targets.

The focus of this textbook is on application, rather than pure knowledge transfer of the results of all chemical biological work (which would also be beyond the scope of a book) It gives the reader, through the specific selection of chemical-biological techniques and concepts, the necessary tools to be able to develop new ways of thinking and thus new therapeutic options in the complex field of chemical biology and drug development. The stated aim of this book is to provide concrete solutions and inspiration to students, (post)graduate students, and experienced scientists at universities as well as in industry in their problems. After an introduction to the problems addressed by chemical biology in drug discovery, the three levels of molecular biology dogma: DNA, RNA and proteins and their role as drug targets serve as the common thread of this book. This book is a translation of the original German 1st edition Chemische Biologie by Marco F. Schmidt, published by Springer-Verlag GmbH Germany, part of Springer Nature in 2020. The translation was done with the help of artificial intelligence (machine translation by the service DeepL.com) A subsequent human revision was done primarily in terms of content, so that the book will read stylistically differently from a conventional translation. Springer Nature works continuously to further the development of tools for the production of books and on the related technologies to support the authors. Marco F. Schmidt is co-founder and Chief Scientific Officer of biotx.ai Inc. which develops Artificial Intelligence for biomedical data analysis. Together with his team, he researches how machine learning can be used to identify drug targets and predict the clinical effect of drug candidates. He studied biochemistry at the FU Berlin and in Tubingen, received his PhD in chemical biology at the FMP Berlin and worked on new drug concepts at the University of Cambridge.

ISBN: 9783662644126$q(electronic bk.)

Standard No.: 10.1007/978-3-662-64412-6doiSubjects--Topical Terms:

918978
Chemical biology.

LC Class. No.: QH313.5.C44 / S36 2022

Dewey Class. No.: 572.3

Chemical biology and drug discovery
LDR:03783nmm a2200361 a 4500 001 618937
003 DE-He213
005 20220131213213.0
006 m d
007 cr nn 008maaau
008 221103s2022 gw s 0 eng d
020 $a 9783662644126$q(electronic bk.)
020 $a 9783662644119$q(paper)
024 7 $a 10.1007/978-3-662-64412-6 $2 doi
035 $a 978-3-662-64412-6
040 $a GP $c GP
041 1 $a eng $h ger
050 4 $a QH313.5.C44 $b S36 2022
072 7 $a PNN $2 bicssc
072 7 $a PSB $2 bicssc
072 7 $a SCI013040 $2 bisacsh
072 7 $a PNN $2 thema
072 7 $a PSB $2 thema
082 0 4 $a 572.3 $2 23
090 $a QH313.5.C44 $b S353 2022
100 1 $a Schmidt, Marco F. $3 918977
240 1 0 $a Chemische Biologie. $l English
245 1 0 $a Chemical biology and drug discovery $h [electronic resource] / $c by Marco F. Schmidt.
260 $a Berlin, Heidelberg : $b Springer Berlin Heidelberg : $b Imprint: Springer, $c 2022.
300 $a ix, 223 p. : $b ill. (chiefly col.), digital ; $c 24 cm.
505 0 $a Foreword -- Introduction -- Part I: Chemical Biology and Drug Development -- Chemical Biology - a Holistic Science -- Drug Development -- From Genomics to Chemical Biology -- Part II: DNA -- DNA - blueprint of proteins -- Genomic Variation -- Gene Therapy and Genome Editing -- Part III: RNA -- RNA - information and function carrier -- RNA Interference in Drug Development -- Part IV: Proteins -- Peptides & proteins -- Proteins as drug targets -- Chemical genomics - From target protein to drug -- From target protein to macromolecular drug - Biologics -- Chemical proteomics: From drug to target protein -- Chemical genetics: validation of drug target by elucidation of signaling pathway -- Chemical biology - Addressing new drug targets.
520 $a The focus of this textbook is on application, rather than pure knowledge transfer of the results of all chemical biological work (which would also be beyond the scope of a book) It gives the reader, through the specific selection of chemical-biological techniques and concepts, the necessary tools to be able to develop new ways of thinking and thus new therapeutic options in the complex field of chemical biology and drug development. The stated aim of this book is to provide concrete solutions and inspiration to students, (post)graduate students, and experienced scientists at universities as well as in industry in their problems. After an introduction to the problems addressed by chemical biology in drug discovery, the three levels of molecular biology dogma: DNA, RNA and proteins and their role as drug targets serve as the common thread of this book. This book is a translation of the original German 1st edition Chemische Biologie by Marco F. Schmidt, published by Springer-Verlag GmbH Germany, part of Springer Nature in 2020. The translation was done with the help of artificial intelligence (machine translation by the service DeepL.com) A subsequent human revision was done primarily in terms of content, so that the book will read stylistically differently from a conventional translation. Springer Nature works continuously to further the development of tools for the production of books and on the related technologies to support the authors. Marco F. Schmidt is co-founder and Chief Scientific Officer of biotx.ai Inc. which develops Artificial Intelligence for biomedical data analysis. Together with his team, he researches how machine learning can be used to identify drug targets and predict the clinical effect of drug candidates. He studied biochemistry at the FU Berlin and in Tubingen, received his PhD in chemical biology at the FMP Berlin and worked on new drug concepts at the University of Cambridge.
650 0 $a Chemical biology. $3 918978
650 0 $a Drug development. $3 190608
650 1 4 $a Bioorganic Chemistry. $3 275016
650 2 4 $a Life Sciences. $3 273679
650 2 4 $a Medical Biochemistry. $3 274286
650 2 4 $a Medicinal Chemistry. $3 275183
650 2 4 $a Biomedical Research. $3 243625
650 2 4 $a Pharmacy. $3 218145
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-662-64412-6
950 $a Chemistry and Materials Science (SpringerNature-11644)